Form 4: NeueHealth CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
NeueHealth CEO George Lawrence Mikan III sold shares of common stock on March 14 and 15, 2024, to cover tax withholding obligations upon the vesting of restricted stock units.
Summary
- On March 14, 2024, George Lawrence Mikan III, CEO and President of NeueHealth, Inc., sold 2,398 shares of common stock at a weighted average price of $7.06.
- The shares were sold in multiple transactions with prices ranging from $6.76 to $7.45 per share.
- On March 15, 2024, Mikan sold an additional 3,442 shares of common stock at a weighted average price of $7.10.
- These shares were sold in multiple transactions with prices ranging from $6.98 to $7.40 per share.
- The sales were to cover tax withholding obligations upon the vesting of restricted stock units and were not discretionary transactions.
- Following these transactions, Mikan directly owns 69,822 shares of NeueHealth, Inc.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction (stock sale for tax obligations) by an executive, which is neither particularly positive nor negative.
Industry Context
This filing is a routine disclosure of stock sales by a company executive to cover tax obligations, which is a common practice.
Stakeholder Impact
- The stock sales could have a minor, temporary impact on the stock price, but are unlikely to have a significant long-term effect on shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/14/2024 | CEO sold 2,398 shares of common stock. |
| 03/15/2024 | CEO sold 3,442 shares of common stock. |
| 03/18/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.